INTRODUCTION
============

Summary measures of population health (SMPH) are a combination of a fatal health condition that can lead to death and a health condition of a non-fatal health condition.[@B1] SMPH, also referred to as a composite indicator, is distinguished by indicators of health gap or life year and indicators of life expectancy.[@B2][@B3] The indictors of health gap are again divided into the disability adjusted life year (DALY) which is utilized in the global burden of disease (GBD) study[@B4] and the quality adjusted life year (QALY) which is mainly used as the outcome index of the cost-utility analysis.[@B5] Furthermore, indicators of life expectancy are also classified into the healthy life expectancy (HALE) which is utilized in the GBD study[@B4] and the quality adjusted life expectancy (QALE) using health-related quality of life.[@B6]

Among the SMPH, DALY and HALE are used to estimate the GBD, but there have been also many studies on DALY and HALE in Korea.[@B7][@B8][@B9][@B10] In order to calculate DALY and HALE, disability weight is an essential factor. The disability weight is a measure of the level of disability of particular health state and diseases, and its value lies between 0 (full health, no disability) and 1 (disability level in a state such as death).[@B11] That is, the disability weight plays a bridging role between mortality and morbidity when estimating DALY and HALE. Therefore, it is necessary to be able to estimate the disability weight appropriately and reliably.[@B12] If the disability weight of a specific disease is overestimated, the burden of the disease may be overestimated. Conversely, if the disability weight is underestimated, there is a possibility of underestimating the burden of disease.

Since 1996, many studies have been conducted to estimate disability weights in many countries.[@B11][@B13][@B14][@B15] Most recently, disability weights for the GBD 2013 study was performed using paired comparison as a main valuation method and disability weights for 235 health states were estimated adding the results of European disability weight study.[@B13][@B14] In the case of Korea, two disability weights studies for the Korean Burden of Disease (KBD) 2012 were conducted most recently.[@B11][@B15] In the first study, a total of 496 physician and medical students participated in self-administered web-based surveys and a total of 228 disability weights of disease causes for calculating the incidence-based DALY were estimated.[@B11] In the second study, a total of 2,728 and 3,188 general public participated in the household and web-based survey, respectively, and a total of 258 disability weights of health states for calculating the prevalence-based DALY were estimated.[@B15]

However, disability weights calculated in the past may not be valid at this time because of the emergence of new diseases or health states, changes in disease characteristics, development of treatment methods, and changes in social perspectives on disability.[@B12] Therefore, it is necessary to continually evaluate the validity of disability weights and to revise disability weights. In particular, there is an increasing need to calculate the more valid burden of diseases reflecting the severity level of diseases and attempts are being made to calculate the disability weight reflecting the severity level of health states.[@B9][@B15] However, there was no attempt to calculate the disability weights for disease causes reflecting the severity level of diseases.

For the KBD 2015 study, we have amended disability weights for causes of disease adapting the methodology of the KBD disability weight 2012 study. In particular, we attempted to further refine the severity level of diseases, such as cancer and diabetes, and to determine their disability weights.

METHODS
=======

Study design and participants
-----------------------------

We conducted a self-administered web-based survey in Korea, adapting the methodology of a preceding disability weights measurement study.[@B11] The survey was conducted from November 2016 to March 2017. In this study, we recruited study participants who could be expected to have enough knowledge about causes of disease. Specifically, physicians and medical students who were attending in the third or fourth grade of a regular course participated in the survey. We recruited participants through promotion of the survey in the lectures of medical colleges and an announcement at medical conferences, seminars and meetings.

Valuation method and causes of disease
--------------------------------------

Each participant responded to his or her age, gender, specialty, and position at the beginning of the survey. Next, the participant evaluated the causes of diseases using a ranking method. That is, the participants ranked causes of disease in order of good health in the ranking method, considering mental and physical problems. Because the survey was conducted for the medical professionals, the descriptions of causes of disease were not developed and the response was obtained by presenting the causes of disease itself to the survey participants. We used a method ranking five causes of disease, which proved to be effective in previous study.[@B16]

The five causes of disease were randomly selected among the 289 causes of disease. Among the 289 causes of disease, 211 causes of disease were taken from the previous disability weights measurement study without subdividing severity level.[@B11] For 60 causes of disease, the degree of severity was further subdivided. For example, gastric cancer was classified into four stages: gastric cancer stage I, gastric cancer stage II, gastric cancer stage III, gastric cancer IV. Osteoarthritis was subdivided into three stages: osteoarthritis (mild), osteoarthritis (moderate), osteoarthritis (severe). Diabetes mellitus was classified into two stages: diabetes mellitus without complications and diabetes mellitus with complications. Furthermore, 16 causes of disease were included in the list for the verification of the disability weight model of multimorbidity. For example, two or more causes of disease, such as patients with diabetes mellitus and osteoarthritis, were included in the list. The remaining two causes of disease were 'full health' and 'being dead.' These were included for use as an anchor points in the analysis.

Each participant performed a total of 20 ranking methods. In order to obtain a sufficient number of comparisons between 'full health' or 'being dead' and other causes of disease, 'full health' should be included in question 1 and 11, whereas 'being dead' should be included in question 5, 10, 15, and 20.

Analysis
--------

Initially, we conducted descriptive analyses for determining the characteristics of socio-demographic factors of the participants. Before the disability weight analyses, illogical response that 'full health' was not listed as the healthiest condition were excluded from the results. Then, we converted the ranked data into paired comparison data.[@B16] For example, if the orders of causes of disease were "C1 \> C2 \> C3 \> C4 \> C5," they were converted as follows: "C1 \> C2," "C1 \> C3," "C1 \> C4," "C1 \> C5," "C2 \> C3," "C2 \> C4," "C2 \> C5," "C3 \> C4," "C3 \> C5," and "C4 \> C5." After conversion, we ran a probit regression according to the analytic methodology of previous studies.[@B11][@B15] The stated preference between the two causes of disease in the paired comparison data were regarded as the dependent variable. The 289 causes of disease were treated as independent variables and created as dummy variables with 'being dead' as the reference. The predicted probabilities for each cause of disease were calculated from the coefficient estimates of the probit regression. 'Being dead (1)' and 'Full health (0)' were utilized as anchor points to rescale the predicted probability of each cause of disease on a scale from 0 to 1. Using the 95% confidence interval (CI) of the predicted probabilities, the 95% CIs of disability weight for causes of disease were estimated.

The calculated disability weights from this study were compared to those calculated in a preceding disability weights measurement study.[@B11] Stata 13.1 software (StataCorp, College Station, TX, USA) was used for all statistical analyses. *P* values less than 0.05 were regarded statistically significant in this study.

Ethics statement
----------------

This study was approved by the Institutional Review Board of the Asan Medical Center (IRB No. 2016-1271). Each participant was informed about the purpose of the survey and only those individuals who provided informed consent joined this survey.

RESULTS
=======

A total of 605 participants performed the survey. [Table 1](#T1){ref-type="table"} shows the details of the participants\' socio-demographic characteristics. The participants in the 30s were predominant and the men participants outnumbered women participants in the survey. The specialists accounted for about 60% of the total survey participants, and the medical part specialists were more than the surgical part specialists.

###### Characteristics of the study participants by type of survey

![](jkms-34-e60-i001)

  Variables   No. (%)                
  ----------- ---------------------- ------------
  Age, yr                            
              19--29                 206 (34.1)
              30--39                 395 (65.3)
              ≤ 40                   4 (0.7)
  Gender                             
              Men                    450 (74.4)
              Women                  155 (25.6)
  Specialty                          
              Medical part           193 (31.9)
              Surgical part          78 (12.9)
              Others                 334 (55.2)
  Position                           
              Medical student        164 (27.1)
              General practitioner   56 (9.3)
              Resident               6 (1.0)
              Specialist             362 (59.8)
              Others                 17 (2.8)
  Total       605 (100.0)            

Of the 1,210 questions that included 'full health,' eight (0.7%) were illogical responses for which the 'full health' was not listed as the best health status. All of these illogical responses occurred in question 11. [Table 2](#T2){ref-type="table"} shows the disability weights and their 95% CIs for 289 causes of disease. The cause of disease with highest disability weight was 'trachea, bronchus and lung cancers (stage 4) (0.906),' followed by 'kidney cancer (stage 4) (0.902)' and 'brain and nervous system cancers (0.888).' The cause of disease with lowest disability weight was 'acne vulgaris (0.049),' followed by 'dental caries (0.065)' and 'allergic rhinitis (0.087).' More than half of the causes of disease (n = 166, 57.4%) had disability weight values of less than 0.5 ([Fig. 1](#F1){ref-type="fig"}). Furthermore, disability weights for about 70% of causes of disease (n = 201, 69.6%) were located between 0.2 and 0.7.

###### Disability weights for 289 causes of disease
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  No.   Cause of disease                                                             Disability weight   95% CI   
  ----- ---------------------------------------------------------------------------- ------------------- -------- -------
  1     Tuberculosis                                                                 0.519               0.462    0.575
  2     HIV disease resulting in mycobacterial infection                             0.746               0.694    0.792
  3     HIV disease resulting in other specified or unspecified diseases             0.787               0.740    0.828
  4     Cholera                                                                      0.355               0.298    0.415
  5     Other salmonella infections                                                  0.279               0.229    0.334
  6     Shigellosis                                                                  0.248               0.198    0.303
  7     Enteropathogenic *E. coli* infection                                         0.290               0.236    0.347
  8     Enterotoxigenic *E. coli* infection                                          0.267               0.216    0.323
  9     *Campylobacter* enteritis                                                    0.268               0.218    0.324
  10    Amoebiasis                                                                   0.380               0.321    0.440
  11    Cryptosporidiosis                                                            0.518               0.459    0.577
  12    Rotaviral enteritis                                                          0.188               0.146    0.236
  13    Intestinal infection                                                         0.270               0.217    0.327
  14    Typhoid and paratyphoid fevers                                               0.382               0.322    0.445
  15    Influenza                                                                    0.149               0.112    0.194
  16    Pneumococcal pneumonia                                                       0.427               0.369    0.486
  17    *H. influenzae* type B pneumonia                                             0.407               0.348    0.468
  18    Respiratory syncytial virus pneumonia                                        0.367               0.309    0.428
  19    Upper respiratory infections                                                 0.131               0.096    0.173
  20    Otitis media                                                                 0.176               0.134    0.224
  21    Pneumococcal meningitis                                                      0.590               0.532    0.645
  22    *H. influenzae* type B meningitis                                            0.557               0.498    0.614
  23    Meningococcal infection                                                      0.530               0.470    0.588
  24    Encephalitis                                                                 0.687               0.632    0.737
  25    Diphtheria                                                                   0.340               0.284    0.398
  26    Whooping cough                                                               0.253               0.203    0.307
  27    Tetanus                                                                      0.525               0.466    0.583
  28    Measles                                                                      0.254               0.203    0.312
  29    Varicella                                                                    0.241               0.193    0.293
  30    Malaria                                                                      0.438               0.381    0.497
  31    Chagas disease                                                               0.547               0.489    0.604
  32    Leishmaniasis                                                                0.408               0.350    0.467
  33    African trypanosomiasis                                                      0.432               0.376    0.490
  34    Schistosomiasis                                                              0.381               0.323    0.442
  35    Cysticercosis                                                                0.372               0.316    0.431
  36    Echinococcosis                                                               0.412               0.354    0.471
  37    Lymphatic filariasis                                                         0.418               0.359    0.479
  38    Onchocerciasis                                                               0.319               0.264    0.378
  39    Trachoma                                                                     0.437               0.376    0.498
  40    Dengue                                                                       0.395               0.337    0.455
  41    Yellow fever                                                                 0.504               0.444    0.563
  42    Rabies                                                                       0.655               0.598    0.709
  43    Ascariasis                                                                   0.231               0.183    0.284
  44    Trichuriasis                                                                 0.253               0.202    0.309
  45    Hookworm disease                                                             0.241               0.193    0.295
  46    Food-borne trematodiases                                                     0.275               0.224    0.330
  47    Tsutsugamushi fever                                                          0.386               0.329    0.445
  48    Typhus fever                                                                 0.390               0.332    0.449
  49    Hantaan virus disease                                                        0.472               0.411    0.532
  50    Intestinal helminth                                                          0.267               0.217    0.321
  51    Maternal hemorrhage                                                          0.514               0.453    0.575
  52    Maternal sepsis                                                              0.749               0.699    0.795
  53    Hypertensive disorders of pregnancy                                          0.455               0.395    0.516
  54    Obstructed labor                                                             0.462               0.404    0.521
  55    Abortion                                                                     0.300               0.245    0.359
  56    Preterm birth complications                                                  0.517               0.456    0.576
  57    Neonatal encephalopathy (birth asphyxia and birth trauma)                    0.858               0.815    0.893
  58    Sepsis and other infectious disorders of the newborn baby                    0.711               0.658    0.759
  59    Protein-energy malnutrition                                                  0.414               0.356    0.474
  60    Iodine deficiency                                                            0.200               0.155    0.250
  61    Vitamin A deficiency                                                         0.153               0.115    0.197
  62    Iron-deficiency anemia                                                       0.170               0.131    0.216
  63    Syphilis                                                                     0.452               0.393    0.511
  64    Sexually transmitted chlamydial diseases                                     0.253               0.205    0.307
  65    Gonococcal infection                                                         0.307               0.255    0.364
  66    Trichomoniasis                                                               0.316               0.259    0.377
  67    Herpes genitalia                                                             0.286               0.231    0.345
  68    Acute hepatitis A                                                            0.364               0.307    0.424
  69    Acute hepatitis B                                                            0.431               0.372    0.491
  70    Acute hepatitis C                                                            0.501               0.441    0.561
  71    Acute hepatitis E                                                            0.467               0.407    0.526
  72    Leprosy                                                                      0.613               0.558    0.665
  73    Legionnaires\' disease                                                       0.345               0.288    0.405
  74    Leptospirosis                                                                0.415               0.355    0.475
  75    Rubella                                                                      0.359               0.301    0.418
  76    Mumps                                                                        0.202               0.157    0.253
  77    Esophageal cancer                                                            0.841               0.802    0.875
  78    Stomach cancer (stage 1)                                                     0.462               0.403    0.520
  79    Stomach cancer (stage 2)                                                     0.669               0.614    0.720
  80    Stomach cancer (stage 3)                                                     0.823               0.780    0.860
  81    Stomach cancer (stage 4)                                                     0.880               0.840    0.912
  82    Liver cancer secondary to hepatitis B                                        0.796               0.749    0.837
  83    Liver cancer secondary to hepatitis C                                        0.802               0.755    0.842
  84    Liver cancer secondary to alcohol use (stage 1)                              0.603               0.541    0.661
  85    Liver cancer secondary to alcohol use (stage 2)                              0.718               0.666    0.766
  86    Liver cancer secondary to alcohol use (stage 3)                              0.785               0.737    0.827
  87    Liver cancer secondary to alcohol use (stage 4)                              0.876               0.838    0.907
  88    Larynx cancer                                                                0.824               0.784    0.859
  89    Trachea, bronchus and lung cancers (stage 1)                                 0.600               0.542    0.656
  90    Trachea, bronchus and lung cancers (stage 2)                                 0.738               0.686    0.785
  91    Trachea, bronchus and lung cancers (stage 3)                                 0.758               0.710    0.801
  92    Trachea, bronchus and lung cancers (stage 4)                                 0.906               0.873    0.932
  93    Breast cancer (stage 1)                                                      0.439               0.379    0.500
  94    Breast cancer (stage 2)                                                      0.597               0.535    0.657
  95    Breast cancer (stage 3)                                                      0.724               0.671    0.771
  96    Breast cancer (stage 4)                                                      0.864               0.826    0.895
  97    Cervical cancer (stage 1)                                                    0.431               0.372    0.491
  98    Cervical cancer (stage 2)                                                    0.553               0.493    0.611
  99    Cervical cancer (stage 3)                                                    0.813               0.767    0.851
  100   Cervical cancer (stage 4)                                                    0.855               0.815    0.889
  101   Uterine cancer                                                               0.711               0.661    0.757
  102   Prostate cancer (stage 1)                                                    0.458               0.399    0.518
  103   Prostate cancer (stage 2)                                                    0.613               0.552    0.672
  104   Prostate cancer (stage 3)                                                    0.742               0.692    0.787
  105   Prostate cancer (stage 4)                                                    0.838               0.795    0.874
  106   Colon and rectum cancers (stage 1)                                           0.496               0.436    0.556
  107   Colon and rectum cancers (stage 2)                                           0.689               0.631    0.742
  108   Colon and rectum cancers (stage 3)                                           0.841               0.798    0.878
  109   Colon and rectum cancers (stage 4)                                           0.870               0.833    0.900
  110   Mouth cancer                                                                 0.870               0.828    0.905
  111   Nasopharynx cancer                                                           0.766               0.716    0.811
  112   Cancer of other part of pharynx and oropharynx                               0.811               0.764    0.851
  113   Gallbladder and biliary tract cancer                                         0.800               0.752    0.843
  114   Pancreatic cancer                                                            0.879               0.843    0.909
  115   Malignant melanoma of skin                                                   0.786               0.737    0.829
  116   Non-melanoma skin cancer                                                     0.649               0.593    0.702
  117   Ovarian cancer                                                               0.776               0.727    0.821
  118   Testicular cancer                                                            0.692               0.637    0.744
  119   Kidney cancer (stage 1)                                                      0.570               0.509    0.627
  120   Kidney cancer (stage 2)                                                      0.731               0.678    0.778
  121   Kidney cancer (stage 3)                                                      0.809               0.762    0.849
  122   Kidney cancer (stage 4)                                                      0.902               0.870    0.927
  123   Other urinary organ cancers                                                  0.711               0.656    0.761
  124   Bladder cancer (stage 1)                                                     0.500               0.441    0.558
  125   Bladder cancer (stage 2)                                                     0.623               0.567    0.676
  126   Bladder cancer (stage 3)                                                     0.769               0.720    0.812
  127   Bladder cancer (stage 4)                                                     0.869               0.830    0.901
  128   Brain and nervous system cancers                                             0.888               0.852    0.918
  129   Thyroid cancer (stage 1)                                                     0.301               0.248    0.359
  130   Thyroid cancer (stage 2)                                                     0.484               0.425    0.543
  131   Thyroid cancer (stage 3)                                                     0.639               0.583    0.691
  132   Thyroid cancer (stage 4)                                                     0.779               0.730    0.822
  133   Hodgkin\'s disease                                                           0.670               0.612    0.725
  134   Non-Hodgkin lymphoma                                                         0.689               0.636    0.737
  135   Multiple myeloma                                                             0.764               0.714    0.808
  136   Leukemia                                                                     0.812               0.765    0.854
  137   Bone and connective tissue cancer                                            0.765               0.717    0.809
  138   Benign neoplasm of brain and other parts of central nervous system           0.505               0.442    0.567
  139   Rheumatic heart disease                                                      0.600               0.542    0.657
  140   Ischemic heart disease                                                       0.534               0.475    0.592
  141   Ischemic stroke (mild)                                                       0.540               0.477    0.601
  142   Ischemic stroke (moderate)                                                   0.787               0.740    0.828
  143   Ischemic stroke (severe)                                                     0.840               0.799    0.875
  144   Hemorrhagic and other non-ischemic stroke                                    0.785               0.738    0.825
  145   Hypertensive heart disease                                                   0.502               0.444    0.560
  146   Cardiomyopathy and myocarditis                                               0.717               0.661    0.768
  147   Atrial fibrillation and flutter                                              0.584               0.526    0.641
  148   Aortic aneurysm                                                              0.647               0.591    0.700
  149   Peripheral vascular disease                                                  0.430               0.368    0.492
  150   Endocarditis                                                                 0.646               0.589    0.700
  151   Hermorrhoid                                                                  0.139               0.103    0.182
  152   Varicose veins of lower extremities                                          0.173               0.132    0.219
  153   Chronic obstructive pulmonary disease (mild)                                 0.408               0.351    0.466
  154   Chronic obstructive pulmonary disease (moderate)                             0.703               0.648    0.754
  155   Chronic obstructive pulmonary disease (severe)                               0.722               0.668    0.771
  156   Pneumoconiosis                                                               0.669               0.614    0.721
  157   Asthma                                                                       0.396               0.337    0.458
  158   Interstitial lung disease and pulmonary sarcoidosis                          0.678               0.623    0.729
  159   Cirrhosis of the liver secondary to hepatitis B                              0.707               0.655    0.755
  160   Cirrhosis of the liver secondary to hepatitis C                              0.706               0.653    0.754
  161   Cirrhosis of the liver secondary to alcohol use (mild)                       0.484               0.424    0.543
  162   Cirrhosis of the liver secondary to alcohol use (moderate)                   0.668               0.612    0.722
  163   Cirrhosis of the liver secondary to alcohol use (severe)                     0.717               0.664    0.765
  164   Peptic ulcer disease                                                         0.260               0.207    0.319
  165   Gastritis and duodenitis                                                     0.144               0.107    0.187
  166   Appendicitis                                                                 0.245               0.196    0.300
  167   Paralytic ileus and intestinal obstruction without hernia                    0.388               0.332    0.446
  168   Inguinal or femoral hernia                                                   0.269               0.220    0.322
  169   Crohn\'s disease                                                             0.597               0.538    0.653
  170   Ulcerative colitis                                                           0.545               0.485    0.604
  171   Vascular disorders of intestine                                              0.515               0.455    0.573
  172   Gallbladder and bile duct disease                                            0.448               0.386    0.511
  173   Pancreatitis                                                                 0.498               0.436    0.559
  174   Gastroesophageal reflux disease                                              0.163               0.123    0.209
  175   Alzheimer\'s disease and other dementias                                     0.736               0.685    0.782
  176   Parkinson\'s disease                                                         0.660               0.606    0.711
  177   Epilepsy                                                                     0.581               0.523    0.637
  178   Multiple sclerosis                                                           0.693               0.640    0.742
  179   Migraine                                                                     0.190               0.148    0.237
  180   Tension-type headache                                                        0.163               0.121    0.212
  181   Schizophrenia                                                                0.666               0.612    0.717
  182   Alcohol use disorders                                                        0.350               0.295    0.407
  183   Opioid use disorders                                                         0.457               0.398    0.517
  184   Cocaine use disorders                                                        0.459               0.401    0.518
  185   Amphetamine use disorders                                                    0.473               0.413    0.534
  186   Cannabis use disorders                                                       0.355               0.299    0.413
  187   Major depressive disorder (mild)                                             0.279               0.229    0.333
  188   Major depressive disorder (moderate)                                         0.528               0.469    0.586
  189   Major depressive disorder (severe)                                           0.569               0.509    0.627
  190   Dysthymia                                                                    0.188               0.145    0.238
  191   Bipolar affective disorder                                                   0.483               0.424    0.542
  192   Panic disorder                                                               0.391               0.335    0.448
  193   Obsessive-compulsive disorder                                                0.321               0.266    0.378
  194   Post-traumatic stress disorder                                               0.415               0.357    0.474
  195   Anorexia nervosa                                                             0.420               0.363    0.478
  196   Bulimia nervosa                                                              0.392               0.334    0.451
  197   Autism                                                                       0.510               0.449    0.570
  198   Asperger\'s syndrome                                                         0.408               0.349    0.469
  199   Attention-deficit hyperactivity disorder                                     0.249               0.200    0.302
  200   Conduct disorder                                                             0.275               0.224    0.331
  201   Idiopathic intellectual disability                                           0.483               0.422    0.543
  202   Borderline personality disorder                                              0.397               0.340    0.455
  203   Diabetes mellitus without complications                                      0.334               0.279    0.391
  204   Diabetes mellitus with complications                                         0.663               0.605    0.717
  205   Acute glomerulonephritis                                                     0.420               0.362    0.480
  206   Chronic kidney disease due to diabetes mellitus                              0.674               0.617    0.727
  207   Chronic kidney disease due to hypertension                                   0.594               0.534    0.652
  208   Tubulointerstitial nephritis, pyelonephritis, and urinary tract infections   0.359               0.302    0.418
  209   Urolithiasis                                                                 0.294               0.242    0.350
  210   Benign prostatic hyperplasia                                                 0.207               0.161    0.259
  211   Men infertility                                                              0.332               0.279    0.389
  212   Urinary incontinence                                                         0.287               0.233    0.345
  213   Uterine fibroids                                                             0.223               0.177    0.274
  214   Polycystic ovarian syndrome                                                  0.399               0.342    0.458
  215   Women infertility                                                            0.362               0.306    0.421
  216   Endometriosis                                                                0.349               0.292    0.408
  217   Genital prolapse                                                             0.404               0.338    0.471
  218   Premenstrual syndrome                                                        0.136               0.101    0.179
  219   Thalassemias                                                                 0.485               0.425    0.545
  220   Sickle cell disorders                                                        0.552               0.494    0.609
  221   G6PD deficiency                                                              0.519               0.458    0.580
  222   Rheumatoid arthritis                                                         0.451               0.392    0.510
  223   Osteoarthritis (mild)                                                        0.216               0.171    0.268
  224   Osteoarthritis (moderate)                                                    0.415               0.357    0.474
  225   Osteoarthritis (severe)                                                      0.575               0.515    0.633
  226   Low back pain (mild)                                                         0.138               0.101    0.181
  227   Low back pain (moderate)                                                     0.310               0.257    0.368
  228   Low back pain (severe)                                                       0.456               0.396    0.517
  229   Neck pain                                                                    0.133               0.097    0.177
  230   Gout                                                                         0.390               0.332    0.451
  231   Systemic lupus erythematosus                                                 0.594               0.533    0.651
  232   Neural tube defects                                                          0.782               0.734    0.825
  233   Congenital heart anomalies                                                   0.679               0.622    0.731
  234   Cleft lip and cleft palate                                                   0.313               0.258    0.372
  235   Down\'s syndrome                                                             0.590               0.533    0.645
  236   Eczema                                                                       0.135               0.098    0.179
  237   Psoriasis                                                                    0.235               0.187    0.288
  238   Cellulitis                                                                   0.273               0.222    0.329
  239   Abscess, impetigo, and other bacterial skin diseases                         0.267               0.215    0.324
  240   Scabies                                                                      0.194               0.150    0.245
  241   Fungal skin diseases                                                         0.260               0.210    0.316
  242   Viral skin diseases                                                          0.166               0.126    0.212
  243   Acne vulgaris                                                                0.049               0.029    0.078
  244   Alopecia areata                                                              0.154               0.114    0.200
  245   Pruritus                                                                     0.100               0.069    0.140
  246   Urticaria                                                                    0.106               0.074    0.147
  247   Decubitus ulcer                                                              0.479               0.421    0.536
  248   Glaucoma                                                                     0.449               0.388    0.510
  249   Cataracts                                                                    0.324               0.267    0.383
  250   Macular degeneration                                                         0.457               0.396    0.518
  251   Refraction and accommodation disorders                                       0.206               0.162    0.257
  252   Dental caries                                                                0.065               0.042    0.097
  253   Periodontal disease                                                          0.206               0.161    0.257
  254   Edentulism                                                                   0.471               0.410    0.531
  255   Pedestrian injury by road vehicle                                            0.470               0.410    0.530
  256   Road injury (pedal cycle vehicle)                                            0.315               0.262    0.371
  257   Road injury (motorized vehicle with two wheels)                              0.495               0.435    0.555
  258   Road injury (motorized vehicle with three or more wheels)                    0.597               0.538    0.653
  259   Falls                                                                        0.165               0.126    0.212
  260   Drowning                                                                     0.514               0.454    0.573
  261   Fire, heat and hot substances                                                0.362               0.304    0.423
  262   Poisonings                                                                   0.475               0.415    0.536
  263   Mechanical forces (firearm)                                                  0.547               0.485    0.608
  264   Adverse effects of medical treatment                                         0.362               0.306    0.420
  265   Animal contact (venomous)                                                    0.363               0.304    0.424
  266   Animal contact (non-venomous)                                                0.132               0.095    0.176
  267   Self-harm                                                                    0.516               0.455    0.577
  268   Assault by firearm                                                           0.488               0.429    0.548
  269   Assault by sharp object                                                      0.260               0.212    0.312
  270   Exposure to forces of nature                                                 0.235               0.188    0.287
  271   Collective violence and legal intervention                                   0.432               0.373    0.492
  272   Allergic rhinitis                                                            0.087               0.059    0.123
  273   Atopic dermatitis                                                            0.231               0.182    0.285
  274   Metabolic syndrome                                                           0.304               0.250    0.361
  275   Allergic rhinitis and atopic dermatitis                                      0.166               0.124    0.215
  276   Diabetes mellitus and osteoarthritis                                         0.495               0.436    0.553
  277   Allergic rhinitis and asthma                                                 0.187               0.145    0.236
  278   Allergic rhinitis and osteoarthritis                                         0.192               0.147    0.244
  279   Allergic rhinitis and major depressive disorder                              0.394               0.336    0.453
  280   Major depressive disorder and osteoarthritis                                 0.478               0.418    0.539
  281   Diabetes mellitus and ischemic stroke                                        0.629               0.570    0.685
  282   Diabetes mellitus and tuberculosis                                           0.478               0.418    0.539
  283   Diabetes mellitus, osteoarthritis, and major depressive disorder             0.543               0.484    0.601
  284   Diabetes mellitus, osteoarthritis, and ischemic stroke                       0.667               0.611    0.719
  285   Allergic rhinitis, asthma, and atopic dermatitis                             0.172               0.131    0.219
  286   Diabetes, osteoarthritis, and tuberculosis                                   0.574               0.514    0.632
  287   Diabetes mellitus, osteoarthritis, rheumatoid arthritis                      0.494               0.431    0.556
  288   Full heath                                                                   0.000               0.000    0.000
  289   Being dead                                                                   1.000               1.000    1.000

CI = confidence interval, *E. coli* = *Escherichia coli*.

![Distribution of disability weights.](jkms-34-e60-g001){#F1}

[Fig. 2](#F2){ref-type="fig"} shows the correlation of disability weights between the disability weights for the overlapping causes of disease from this study and a previous study.[@B11] The Pearson correlation coefficient was 0.930. Among 211 overlapping causes of disease, the disability weights for 47 causes of disease from this study, such as 'tuberculosis' and 'decubitus ulcer,' were determined to be higher than that from the previous study; whereas, the disability weights for 163 causes of disease from this study, such as 'schizophrenia' and 'epilepsy,' were estimated to be lower than that from the previous study. The cause of disease with largest difference in disability weight between the two studies was 'falls (0.448)', followed by 'down\'s syndrome (0.318)' and 'asperger\'s syndrome (0.277).' [Supplementary Table 1](#S1){ref-type="supplementary-material"} shows comparisons between the disability weights for overlapping causes of disease from this study and the previous study.[@B11]

![Correlation of disability weights between this study and a previous study.](jkms-34-e60-g002){#F2}

The results of comparing the disability weights of 60 causes of disease that are more subdivided into severity are shown in the [Table 3](#T3){ref-type="table"}. In the case of 'liver cancer secondary to alcohol use,' the disability weights by stage were 0.603 (stage 1), 0.718 (stage 2), 0.785 (stage 3), and 0.876 (stage 4). The disability weight of 'liver cancer secondary to alcohol use' in the previous study was 0.824, located between the stage 3 and 4. On the other hand, in the case of 'thyroid cancer,' the disability weights by stage were 0.301 (stage 1), 0.484 (stage 2), 0.639 (stage 3), and 0.779 (stage 4). The disability weight of 'thyroid cancer' in the previous study was 0.466, located between the stage 1 and 2. Furthermore, the disability weight of 'diabetes mellitus without complications' was 0.334, but the disability weight of 'diabetes mellitus with complications' was 0.663, with a difference of 0.329.

###### Comparison of disability weights among causes of disease subdivided by severity

![](jkms-34-e60-i003)

  Cause of disease                                             Disability weight from this study   95% CI   Disability weight from a previous study   
  ------------------------------------------------------------ ----------------------------------- -------- ----------------------------------------- -------
  Stomach cancer (stage 1)                                     0.462                               0.403    0.520                                     0.724
  Stomach cancer (stage 2)                                     0.669                               0.614    0.720                                     
  Stomach cancer (stage 3)                                     0.823                               0.780    0.860                                     
  Stomach cancer (stage 4)                                     0.880                               0.840    0.912                                     
  Liver cancer secondary to alcohol use (stage 1)              0.603                               0.541    0.661                                     0.824
  Liver cancer secondary to alcohol use (stage 2)              0.718                               0.666    0.766                                     
  Liver cancer secondary to alcohol use (stage 3)              0.785                               0.737    0.827                                     
  Liver cancer secondary to alcohol use (stage 4)              0.876                               0.838    0.907                                     
  Trachea, bronchus and lung cancers (stage 1)                 0.600                               0.542    0.656                                     0.917
  Trachea, bronchus and lung cancers (stage 2)                 0.738                               0.686    0.785                                     
  Trachea, bronchus and lung cancers (stage 3)                 0.758                               0.710    0.801                                     
  Trachea, bronchus and lung cancers (stage 4)                 0.906                               0.873    0.932                                     
  Breast cancer (stage 1)                                      0.439                               0.379    0.500                                     0.704
  Breast cancer (stage 2)                                      0.597                               0.535    0.657                                     
  Breast cancer (stage 3)                                      0.724                               0.671    0.771                                     
  Breast cancer (stage 4)                                      0.864                               0.826    0.895                                     
  Cervical cancer (stage 1)                                    0.431                               0.372    0.491                                     0.744
  Cervical cancer (stage 2)                                    0.553                               0.493    0.611                                     
  Cervical cancer (stage 3)                                    0.813                               0.767    0.851                                     
  Cervical cancer (stage 4)                                    0.855                               0.815    0.889                                     
  Prostate cancer (stage 1)                                    0.458                               0.399    0.518                                     0.701
  Prostate cancer (stage 2)                                    0.613                               0.552    0.672                                     
  Prostate cancer (stage 3)                                    0.742                               0.692    0.787                                     
  Prostate cancer (stage 4)                                    0.838                               0.795    0.874                                     
  Colon and rectum cancers (stage 1)                           0.496                               0.436    0.556                                     0.759
  Colon and rectum cancers (stage 2)                           0.689                               0.631    0.742                                     
  Colon and rectum cancers (stage 3)                           0.841                               0.798    0.878                                     
  Colon and rectum cancers (stage 4)                           0.870                               0.833    0.900                                     
  Kidney cancer (stage 1)                                      0.570                               0.509    0.627                                     0.777
  Kidney cancer (stage 2)                                      0.731                               0.678    0.778                                     
  Kidney cancer (stage 3)                                      0.809                               0.762    0.849                                     
  Kidney cancer (stage 4)                                      0.902                               0.870    0.927                                     
  Bladder cancer (stage 1)                                     0.500                               0.441    0.558                                     0.792
  Bladder cancer (stage 2)                                     0.623                               0.567    0.676                                     
  Bladder cancer (stage 3)                                     0.769                               0.720    0.812                                     
  Bladder cancer (stage 4)                                     0.869                               0.830    0.901                                     
  Thyroid cancer (stage 1)                                     0.301                               0.248    0.359                                     0.466
  Thyroid cancer (stage 2)                                     0.484                               0.425    0.543                                     
  Thyroid cancer (stage 3)                                     0.639                               0.583    0.691                                     
  Thyroid cancer (stage 4)                                     0.779                               0.730    0.822                                     
  Ischemic stroke (mild)                                       0.540                               0.477    0.601                                     0.809
  Ischemic stroke (moderate)                                   0.787                               0.740    0.828                                     
  Ischemic stroke (severe)                                     0.840                               0.799    0.875                                     
  Chronic obstructive pulmonary disease (mild)                 0.408                               0.351    0.466                                     0.690
  Chronic obstructive pulmonary disease (moderate)             0.703                               0.648    0.754                                     
  Chronic obstructive pulmonary disease (severe)               0.722                               0.668    0.771                                     
  Cirrhosis of the liver secondary to alcohol use (mild)       0.484                               0.424    0.543                                     0.614
  Cirrhosis of the liver secondary to alcohol use (moderate)   0.668                               0.612    0.722                                     
  Cirrhosis of the liver secondary to alcohol use (severe)     0.717                               0.664    0.765                                     
  Major depressive disorder (mild)                             0.279                               0.229    0.333                                     0.606
  Major depressive disorder (moderate)                         0.528                               0.469    0.586                                     
  Major depressive disorder (severe)                           0.569                               0.509    0.627                                     
  Diabetes mellitus without complications                      0.334                               0.279    0.391                                     0.593
  Diabetes mellitus with complications                         0.663                               0.605    0.717                                     
  Osteoarthritis (mild)                                        0.216                               0.171    0.268                                     0.370
  Osteoarthritis (moderate)                                    0.415                               0.357    0.474                                     
  Osteoarthritis (severe)                                      0.575                               0.515    0.633                                     
  Low back pain (mild)                                         0.138                               0.101    0.181                                     0.315
  Low back pain (moderate)                                     0.310                               0.257    0.368                                     
  Low back pain (severe)                                       0.456                               0.396    0.517                                     

CI = confidence interval.

DISCUSSION
==========

In this study, we have amended 289 disability weights for causes of disease adapting the methodology of the KBD disability weight 2012 study.[@B11] In particular, we divided the severity of major causes of diseases unlike KBD disability weight 2012 study and estimated their disability weights. A significant number of physicians and medical students participated in the disability weight survey to collect professional and objective opinions on the preferences of the causes of diseases. Furthermore, we maximized the efficiency of the collecting data by using a method ranking five causes of disease that has not yet been attempted in disability weight studies.

In the meantime, paired comparison has been used as a key value evaluation method in the latest international and domestic disability weight studies.[@B11][@B13][@B14][@B15] In this study, however, the ranking method was used as a valuation method, and we determined that the ranking method could be used to calculate the disability weight. Paired comparison has a disadvantage in that the amount of information that can be obtained from a single question is limited, so that the number of items in the survey or the sample size must be increased, if the number of health states or causes of disease to be compared is large.[@B12][@B17] Although the utilization of the ranking method is still low, it can provide more information than the paired comparison. Based on the experience of this study, we expected that the use of the ranking method will increase gradually.

Another difference from previous studies is that we estimated disability weights considering the severity of the causes of disease. We calculated the disability weights of 60 causes of disease considering severity level and compared them with the disability weights in the previous study.[@B11] These results show that prejudice about the severity of cause of disease itself can affect the estimation of disability weight, when estimating the disability weight of cause disease without consideration of severity. For example, disability weight of 'liver cancer secondary to alcohol use' by stage were 0.603 (stage 1), 0.718 (stage 2), 0.785 (stage 3), and 0.876 (stage 4). The disability weight of 'liver cancer secondary to alcohol use' in the previous study was 0.824, located between the stage 3 and 4 (11). On the other hand, disability weight of 'thyroid cancer' by stage were 0.301 (stage 1), 0.484 (stage 2), 0.639 (stage 3), and 0.779 (stage 4). The disability weight of 'thyroid cancer' in the previous study was 0.466, located between the stage 1 and 2.[@B11] These results suggest that it is necessary to calculate the disability weight of causes of disease by reflecting the severity in order to calculate the valid DALY in cases of the large severity difference in the cause of disease or the burden of disease is large. However, in this case, epidemiological data according to severity should be also collected to estimate valid DALY.[@B18][@B19]

When conducting a disability weight study, we typically estimate disability weights for dozens to hundreds of health states or causes of disease, and the calculated disability weight has a value of a limited scale of 0 to 1. Thus, a disability weight for any health state or cause of disease may seem counterintuitive when compared to other health state or cause of disease\'s disability weight, and the absolute magnitude of the disability weight may not seem plausible. This will be the same in this study. However, since there is no golden standard for disability weights, it is not easy to assess the validity of disability weights.[@B12][@B17]

In this study, the following indirect methods were used to evaluate and enhance the validity of the disability weights. First, we examined whether disability weights were reversed in diseases with different levels of severity. For example, when the severity of an ischemic stroke is classified as mild, moderate, or severe, the disability weight of the mild ischemic stroke should be the lowest, and the disability weight of the severe ischemic stroke should be the highest. No such reversal was found in this study. We also tried to compare the disability weights of the present study with the disability weights calculated in a previous study.[@B11] As a result, it was confirmed that there was a fairly high correlation between disability weights from the two studies. Finally, we tried to increase the number of survey participants and to include various specialist among survey participants. Compared to the size of other studies\' samples,[@B17] a significant number of medical professionals have participated in this disability weights survey.

In the recent disability weighting study, the general public is used rather than the healthcare professionals as a participant in the questionnaire.[@B13][@B14][@B15] Considering that the reason for estimating the disability weight is to measure the burden of disease and one of the main reasons for measuring the burden of disease is to determine the priority of resource allocation, it is persuasive to calculate disability weights reflecting the preferences of the general public.[@B12][@B20][@B21] However, it is not easy to precisely get preferences for health states or causes of disease among the general public who do not have a lot of medical knowledge.[@B12][@B22] It is therefore still worthwhile to utilize healthcare professionals in disability weights studies who are expected to be able to objectively compare and evaluate causes of disease with a wealth of knowledge of various health states and causes of diseases.[@B11] It is expected that comparing and integrating the results of the disability weights studies for healthcare professionals, patients, and the general public will become increasingly important.

One limitation of this study is that it could not perform the verification of the disability weight model of multimorbidity properly. We included 16 causes of disease, such as diabetes mellitus with osteoarthritis, in the list of causes of disease and tried to preliminarily evaluate the validity of multiplicative model, additive model, and maximum model for disability weights in multimorbidity.[@B22][@B23] However, it seems that the meaning of having a complex disease in the survey participants is not enough. As a result, there were some cases in which the disability weight did not increase despite the increased number of cause of disease. For example, the disability weights of 'allergic rhinitis' and 'atopic dermatitis' were 0.087 and 0.231, respectively, but the disability weight was estimated to be 0.166 for both of these causes of disease. In order to validate the disability weight model in multimorbidity, further studies are needed considering the level of understanding of participants.

Another limitation is that physicians and medical students participating in the survey may not represent the preference for disease among all medical professionals. However, we tried to increase the number of survey participants and to include various specialist among survey participants. Therefore, it is expected that the disability weight derived from this study will not be significantly different from the judgment of the degree of disability of all medical professionals. Future disability weight studies need to involve more medical professionals with various specialties in the survey.

In conclusion, we have estimated 289 disability weights for causes of disease adapting the methodology of the KBD disability weight 2012 study. The disability weights estimated based on the severity can be used to estimate the more accurate burden of diseases. Furthermore, the disability weights from this study can be utilized to estimate health life expectancy, especially HALE, in Korea.
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###### Supplementary Table 1

Comparison of disability weights for overlapping causes of disease between this study and a previous study
